NRXP
NRX Pharmaceuticals Inc
NASDAQ: NRXP · HEALTHCARE · BIOTECHNOLOGY
$2.98
+2.41% today
Updated 2026-04-30
Market cap
$100.19M
P/E ratio
—
P/S ratio
81.79x
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$2 – $4
Volume
0.9M
NRX Pharmaceuticals Inc (NRXP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-467.30%
ROE
-683.00%
ROA
-121.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | — | $-105000.00 | — | — | — |
| 2018 | — | $66101.00 | — | — | — |
| 2019 | — | $408427.00 | — | — | — |
| 2020 | $0.00 | $-51.78M | — | — | — |
| 2021 | $0.00 | $-93.06M | — | — | — |
| 2022 | $0.00 | $-39.75M | — | — | — |
| 2023 | $0.00 | $-30.15M | — | — | — |
| 2024 | $0.00 | $-25.13M | — | — | — |
| 2025 | $1.23M | $-28.62M | 47.10% | -1,324.41% | -2,336.49% |